Issues of climate change, global warming and sustainability are taking centre stage in political agendas across the globe, causing major restructuring in many sectors. But, what about the healthcare sector?

• How is climate change affecting healthcare?
• How big of a problem is climate change for liver care?
• What public health strategies can be implemented to mitigate the effects of climate change?

You can find more information about the impact of climate change on liver disease care in this publication.

Related podcast episodes: 

EASL Studio Podcast S2E12: Nurse and AHP Focus: Sustainable Hepatology – Insights in nursing initiatives

All EASL Studio Podcasts are available on EASL Campus.

In honour of World Haemochromatosis week (1-7 June 2022) the newly updated EASL Clinical Practice Guidelines on Haemochromatosis will be discussed in this episode of EASL Studio.

Read more

All EASL Studio Podcasts are available on EASL Campus.

Mouse models, based on dietary, chemical or genetic interventions, are designed to serve as tools to understand human liver diseases.

With the number of models increasing:

• What types of models exist for hepatocellular carcinoma?
• How close do they mirror human liver cancer (subtypes)?
• Can they be used to predict therapeutic response?
• What are the best models? For which questions?
• From idea to conception, are we getting lost in translation?

Read this recent Journal of Hepatology article, on which the discussion was based.

Read more

All EASL Studio Podcasts are available on EASL Campus.

In the assessment of disease stage, liver pathology is still largely based on semi-quantitative methods. Recent advances in whole slide imaging have opened the door for the use of artificial intelligence (AI) and the creation of machine learning (ML) algorithms.

• What exactly is digital pathology?
• How can it be implemented in different disease areas?
• Can it be used in routine clinical practice?

Read more

All EASL Studio Podcasts are available on EASL Campus.

In honour of the International Nurse Day (12 May), and to discuss sustainability in liver care, this week we will gain some insights into the impact of nursing initiatives.

• What is sustainable liver care?
• What role do nurses currently play?
• What current nurse-driven activities are promoting a sustainable clinical practice?

Read more

All EASL Studio Podcasts are available on EASL Campus.

Reduce, Refine, Replace. Developed over 50 years ago, the 3Rs provide a framework that urges researchers to think carefully about methods used to investigate scientific questions. In this episode of EASL Studio, we took a closer look at the third R, Replace. With the World Day for Laboratory Animals fast approaching, we discussed how to propel liver cell biology into the third dimension.

• What are the advantages of 3D cultures?
• Can liver cell types be studied in representative manner using 3D cultures?
• More importantly, which part of animal research can be replaced by 3D cell culture experiments?

This and more in EASL Studio: YI Choice.

Read more

All EASL Studio Podcasts are available on EASL Campus.

Discover this EASL Studio Podcast highlighting the recently published EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. Join the faculty as they discuss:

• What effects do anticoagulants have on survival and liver related events in cirrhosis?
• What are the mechanisms of action?
• What type of anticoagulants should be used in patients with cirrhosis?

Read more

All EASL Studio Podcasts are available on EASL Campus.

In recent years social media has become a powerful tool, not only for science dissemination, but also for discussing data and networking.

• What is the impact of dissemination via social media?
• How is social media changing the way data is communicated?
• Should social media activity be considered a professional endeavour?

Listen to this podcast to find out.

Read more

All EASL Studio Podcasts are available on EASL Campus.

Discover this EASL Studio podcast discussing the Baveno Consensus started over 30 years ago with the aim of reviewing current diagnostic and therapeutic strategies and producing updated definitions.

But, with the extension of indication of non-selective beta blockers, has the consensus gone too far?

• Is there enough evidence for their use in already decompensated patients?
• How safe are they in this patient population?
• What do we know about the effects on refractory ascites? Circulatory dysfunction?

Read more

All EASL Studio Podcasts are available on EASL Campus.

This podcast is based on the EASL Studio episode hosted on the occasion of the Rare Liver Diseases Month.

This episode focused on rare liver diseases, in particular, Progressive Familial Intrahepatic Cholestasis (PFIC). Discussions covered:

• Clinical presentation of PFIC
• Current therapeutic options
• The introduction of IBAT/ASBT inhibitors and their impact
• Clinical trials
• Orphan drugs approved for PFIC
• Interview with EMA on the orphan drug programme

This EASL Studio episode was supported by Albireo Pharma and Mirum Pharmaceuticals.

Read more: https://easlcampus.eu/podcasts/easl-studio-podcast-s2e1-new-treatment-options-hereditary-cholestasis-syndromes-game-changer